Literature DB >> 16024047

Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS.

T D Heiman-Patterson1, J S Deitch, E P Blankenhorn, K L Erwin, M J Perreault, B K Alexander, N Byers, I Toman, G M Alexander.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disorder. While most cases of ALS are sporadic, 10-15% are familial, and of these 15-20% possess a mutation in the gene that codes for the enzyme Cu/Zn superoxide dismutase (SOD1). In families of ALS patients with specific SOD1 mutations, affected members demonstrate significant heterogeneity of disease and a large variation in age of onset and severity, suggesting that there are genetic modifiers of disease expression. Transgenic mice expressing mutant forms of SOD1 demonstrate symptoms similar to those seen in patients with ALS. We have observed in our colony of G93A SOD1 transgenic mice a milder phenotype in mice in a C57BL/6J background than the C57BL/6JxSJL/J hybrid background used by Jackson Laboratories to maintain their colony. To investigate the effect of genetic background on phenotype, we have constructed congenic lines on two genetic backgrounds, C57BL/6J (B6) and SJL/J (SJL). We report the influence of background and gender on the survival of these congenic lines compared to the hybrid C57BL/6JxSJL/J background. The mean survival of G93A SOD1 mice in the hybrid B6/SJL background was 130 days, with females surviving significantly longer than males. When compared to the hybrid B6/SJL background, the survival of mice in the SJL background significantly decreased, and the gender difference in survival was maintained. On the other hand, mean survival in the B6 background significantly increased, and in contrast to the B6/SJL and SJL backgrounds, there was no difference in survival between males and females. Transgene copy numbers were verified in all animals to ensure that any phenotypic differences observed were not due to alterations in copy number. This is the first report of a shortened lifespan when the G93A SOD1 transgene is placed on the SJL/J background and an increased survival with the loss of gender influences when the transgene is placed on the C57BL/6J background.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024047     DOI: 10.1016/j.jns.2005.02.006

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  89 in total

1.  Length-dependent axo-terminal degeneration at the neuromuscular synapses of type II muscle in SOD1 mice.

Authors:  C Tallon; K A Russell; S Sakhalkar; N Andrapallayal; M H Farah
Journal:  Neuroscience       Date:  2015-11-18       Impact factor: 3.590

2.  Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.

Authors:  Giuliana Castello Coatti; Miriam Frangini; Marcos C Valadares; Juliana Plat Gomes; Natalia O Lima; Natale Cavaçana; Amanda F Assoni; Mayra V Pelatti; Alexander Birbrair; Antonio Carlos Pedroso de Lima; Julio M Singer; Francisco Marcelo M Rocha; Giovani Loiola Da Silva; Mario Sergio Mantovani; Lucia Inês Macedo-Souza; Merari F R Ferrari; Mayana Zatz
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

Review 3.  Redox modifier genes and pathways in amyotrophic lateral sclerosis.

Authors:  Barrie J Carter; Pervin Anklesaria; Stephanie Choi; John F Engelhardt
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

4.  Diapocynin and apocynin administration fails to significantly extend survival in G93A SOD1 ALS mice.

Authors:  Kari A Trumbull; Donna McAllister; Mandi M Gandelman; Whitney Y Fung; Thomas Lew; Lucy Brennan; Nathan Lopez; Jeff Morré; Balaraman Kalyanaraman; Joseph S Beckman
Journal:  Neurobiol Dis       Date:  2011-07-28       Impact factor: 5.996

5.  The molecular tweezer CLR01 inhibits aberrant superoxide dismutase 1 (SOD1) self-assembly in vitro and in the G93A-SOD1 mouse model of ALS.

Authors:  Ravinder Malik; Helen Meng; Piriya Wongkongkathep; Christian I Corrales; Niki Sepanj; Ryan S Atlasi; Frank-Gerrit Klärner; Thomas Schrader; Melissa J Spencer; Joseph A Loo; Martina Wiedau; Gal Bitan
Journal:  J Biol Chem       Date:  2019-01-02       Impact factor: 5.157

Review 6.  A cellular perspective on conformational disease: the role of genetic background and proteostasis networks.

Authors:  Tali Gidalevitz; Elise A Kikis; Richard I Morimoto
Journal:  Curr Opin Struct Biol       Date:  2010-01-05       Impact factor: 6.809

7.  Mutant glycyl-tRNA synthetase (Gars) ameliorates SOD1(G93A) motor neuron degeneration phenotype but has little affect on Loa dynein heavy chain mutant mice.

Authors:  Gareth T Banks; Virginie Bros-Facer; Hazel P Williams; Ruth Chia; Francesca Achilli; J Barney Bryson; Linda Greensmith; Elizabeth M C Fisher
Journal:  PLoS One       Date:  2009-07-13       Impact factor: 3.240

8.  Sustained expression of TDP-43 and FUS in motor neurons in rodent's lifetime.

Authors:  Cao Huang; Pedro Yuxing Xia; Hongxia Zhou
Journal:  Int J Biol Sci       Date:  2010-07-04       Impact factor: 6.580

9.  Characterization of dysferlin deficient SJL/J mice to assess preclinical drug efficacy: fasudil exacerbates muscle disease phenotype.

Authors:  Sree Rayavarapu; Jack H Van der Meulen; Heather Gordish-Dressman; Eric P Hoffman; Kanneboyina Nagaraju; Susan M Knoblach
Journal:  PLoS One       Date:  2010-09-24       Impact factor: 3.240

10.  Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis.

Authors:  Claudia Pitzer; Carola Krüger; Christian Plaas; Friederike Kirsch; Tanjew Dittgen; Ralph Müller; Rico Laage; Stefan Kastner; Stefanie Suess; Robert Spoelgen; Alexandre Henriques; Hannelore Ehrenreich; Wolf-Rüdiger Schäbitz; Alfred Bach; Armin Schneider
Journal:  Brain       Date:  2008-10-03       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.